Humana Inc. (HUM) Stock Score, Valuation & Financial Research
Humana Inc. is in the Healthcare sector and Medical - Healthcare Plans industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 33/100.
Quick answer for HUM
Humana Inc. currently has a Wall Street Score of 33/100. The stored market price is $409.85. Its financial score is 34/100. Its valuation score is 4/100. The latest WSS change is +2.8 points. These figures are a research snapshot, not a buy or sell recommendation.
What Humana Inc. does
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health
HUM financial snapshot
- Wall Street Score:
- 33/100
- Current price:
- $409.85
- Market capitalization:
- $49.21B
- Revenue:
- $145.68B
- Net income:
- $1.28B
- Free cash flow:
- $375.0M
- Cash:
- $6.89B
- Total debt:
- $14.25B
- EPS:
- 9.87
- P/E ratio:
- 41.5x
- Financial score:
- 34/100
- Valuation score:
- 4/100
- Revenue score:
- 44/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $375.0M, showing positive cash generation.
- The balance sheet shows $6.89B of cash versus $14.25B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +2.8 points: HUM increased 2.8 points because Revenue improved by 7 points, Capital improved by 2 points, Management improved by 17.2 points.
What the numbers mean
Its current valuation score is 4/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 34/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-08-14.
How to research HUM
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.